ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ CoVigi (22. 3. 2021 – 21. 3. 2022)

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	CoVigi CLINICAL EVALUATION PROGRESS REPORT (22/03/2021 – 21/03/2022)
Authors	DEMLOVÁ Regina JANSKÁ Kateřina
Year of publication	2022
MU Faculty or unit	Faculty of Medicine
Web	COVIGI
Description	The clinical trial CoVigi aims to obtain information on the efficacy and safety of COVID-19 vaccines by determining antibody levels and cellular immunity, collecting data on adverse events and effects, and monitoring the incidence of COVID-19 disease over a period of two years. In addition, the circulating immune profile of oncological patients is monitored, and the determined objectives and parameters are evaluated in connection with the type of oncological treatment administered. It is planned to enroll 565 adult subjects in 3 study centers. The trial's sponsor is Masaryk University.
Related projects:	Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)